Philippe Durieux
Directeur Général chez Sopartec SA
Profil
Philippe Durieux is currently the Chief Executive Officer at Sopartec SA since 2006.
He is also the Chairman at CISSOID SA, Director at Xylowatt SA, Director at GreenWatt SA, and Director at Novadip Biosciences SA since 2017.
Previously, he worked as a Director at iTeos Therapeutics SA. Mr. Durieux completed his graduate degree at Hautes Etudes Commerciales and his undergraduate degree at Université Catholique de Louvain.
Postes actifs de Philippe Durieux
| Sociétés | Poste | Début |
|---|---|---|
Sopartec SA
 Sopartec SA Investment ManagersFinance Sopartec SA is the investment and technology valorization arm of Université Catholique de Louvain (UCL) and was founded in 1942. Sopartec SA is headquartered in Louvain-la-Neuve, Belgium. | Directeur Général | 01/09/2006 |
CISSOID SA
 CISSOID SA Electrical ProductsProducer Manufacturing CISSOID SA manufactures industrial voltage regulators, oscillators and related electrical equipment. It offers temperature semiconductor solutions, delivering standard products and custom solutions for power management, power conversion and signal conditioning in extreme temperature and harsh environments. The firm's products include enable energy, weight and cost savings in lighter, cooling-free and more compact electronic systems. The company was founded by Pierre Delatte, Demeus Laurent, Vincent Dessard and Denis Flandre in 2000 and is headquartered in Mont-Saint-Guibert, Belgium. | Président | - |
Xylowatt SA
 Xylowatt SA Electric UtilitiesUtilities Xylowatt SA designs, develops and builds gasification reactors for energy conversion from biomass and waste products. It offers NOTAR gasification reactor that produces syngas; and expert services. The company’s products convert energy from clean wood waste, contaminated wood, creosoted wood, radionuclides contaminated wood, agro residues, and sewage sludge. Its product is used in CHP and industrial applications. The company was founded in 2001 and it is headquartered in Charleroi, Belgium. | Directeur/Membre du Conseil | - |
Novadip Biosciences SA
 Novadip Biosciences SA BiotechnologyHealth Technology Novadip Biosciences SA operates as a advanced biopharmaceutical company that develops cell-based therapies to treat patients with critical size bone defects and severe bone diseases. Its proprietary product, Creost, is a natural scaffold-free and tridimensional bone structure, which reconstructs large bone defects without the need of any biomaterial. The firm is a osteogenic living implant with a mineralization similar to a real bone. Its Creost is an autologous cell based-therapy product obtained from Adipose-derived Mesenchymal Stem Cells (AMSCs) which promotes (i) a perfect engraftment without any scaffold and (ii) a tissue remodeling with all native bone properties. Novadip Biosciences was founded by Jean-Fran?ois Pollet and Denis Dufrane in 2013 and is headquartered in Louvain-la-Neuve, Belgium. | Directeur/Membre du Conseil | 30/05/2017 |
GreenWatt SA
 GreenWatt SA Electric UtilitiesUtilities GreenWatt SA designs and installs on-site bio-methanization plants. It engages in the provision of renewable energy and recycling solutions for waste bio-methanization cogeneration. The company was founded by Marc-Jean Spiltoir, Patrick Alexandre Thierry Rene van den Broucke, and Therese Marie Wathelet Florence in 2004 and is headquartered in Louvain-la-Neuve, Belgium. | Directeur/Membre du Conseil | - |
Anciens postes connus de Philippe Durieux
| Sociétés | Poste | Fin |
|---|---|---|
iTeos Therapeutics SA
 iTeos Therapeutics SA Pharmaceuticals: MajorHealth Technology iTeos Therapeutics SA engages in the discovery of immunomodulators for cancer therapy. It operates as a biotechnology company which focuses on targeting metabolism of the tumor microenvironment through development of small-molecule immunomodulators for cancer treatment. The firm develops small molecules designed to target the tumor microenvironment by inhibiting cancer-induced immune suppression. Targeting such resistance mechanisms will enhance the clinical efficacy of both standards of care treatments as well as the newer immunomodulatory therapies based on the blockade of immune checkpoints. The company was founded in 2011 by Michel Detheux and Benoit Van den Eynde and is headquartered in Gosselies, Belgium. | Directeur/Membre du Conseil | - |
Formation de Philippe Durieux
| Hautes Etudes Commerciales | Graduate Degree |
| Université Catholique de Louvain | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 6 |
|---|---|
Sopartec SA
Sopartec SA Investment ManagersFinance Sopartec SA is the investment and technology valorization arm of Université Catholique de Louvain (UCL) and was founded in 1942. Sopartec SA is headquartered in Louvain-la-Neuve, Belgium. | Finance |
CISSOID SA
CISSOID SA Electrical ProductsProducer Manufacturing CISSOID SA manufactures industrial voltage regulators, oscillators and related electrical equipment. It offers temperature semiconductor solutions, delivering standard products and custom solutions for power management, power conversion and signal conditioning in extreme temperature and harsh environments. The firm's products include enable energy, weight and cost savings in lighter, cooling-free and more compact electronic systems. The company was founded by Pierre Delatte, Demeus Laurent, Vincent Dessard and Denis Flandre in 2000 and is headquartered in Mont-Saint-Guibert, Belgium. | Producer Manufacturing |
Xylowatt SA
Xylowatt SA Electric UtilitiesUtilities Xylowatt SA designs, develops and builds gasification reactors for energy conversion from biomass and waste products. It offers NOTAR gasification reactor that produces syngas; and expert services. The company’s products convert energy from clean wood waste, contaminated wood, creosoted wood, radionuclides contaminated wood, agro residues, and sewage sludge. Its product is used in CHP and industrial applications. The company was founded in 2001 and it is headquartered in Charleroi, Belgium. | Utilities |
GreenWatt SA
GreenWatt SA Electric UtilitiesUtilities GreenWatt SA designs and installs on-site bio-methanization plants. It engages in the provision of renewable energy and recycling solutions for waste bio-methanization cogeneration. The company was founded by Marc-Jean Spiltoir, Patrick Alexandre Thierry Rene van den Broucke, and Therese Marie Wathelet Florence in 2004 and is headquartered in Louvain-la-Neuve, Belgium. | Utilities |
iTeos Therapeutics SA
iTeos Therapeutics SA Pharmaceuticals: MajorHealth Technology iTeos Therapeutics SA engages in the discovery of immunomodulators for cancer therapy. It operates as a biotechnology company which focuses on targeting metabolism of the tumor microenvironment through development of small-molecule immunomodulators for cancer treatment. The firm develops small molecules designed to target the tumor microenvironment by inhibiting cancer-induced immune suppression. Targeting such resistance mechanisms will enhance the clinical efficacy of both standards of care treatments as well as the newer immunomodulatory therapies based on the blockade of immune checkpoints. The company was founded in 2011 by Michel Detheux and Benoit Van den Eynde and is headquartered in Gosselies, Belgium. | Health Technology |
Novadip Biosciences SA
Novadip Biosciences SA BiotechnologyHealth Technology Novadip Biosciences SA operates as a advanced biopharmaceutical company that develops cell-based therapies to treat patients with critical size bone defects and severe bone diseases. Its proprietary product, Creost, is a natural scaffold-free and tridimensional bone structure, which reconstructs large bone defects without the need of any biomaterial. The firm is a osteogenic living implant with a mineralization similar to a real bone. Its Creost is an autologous cell based-therapy product obtained from Adipose-derived Mesenchymal Stem Cells (AMSCs) which promotes (i) a perfect engraftment without any scaffold and (ii) a tissue remodeling with all native bone properties. Novadip Biosciences was founded by Jean-Fran?ois Pollet and Denis Dufrane in 2013 and is headquartered in Louvain-la-Neuve, Belgium. | Health Technology |
